Capha Pharmaceuticals Inc. Stock

Stocks

25-07-31	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-28	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-04-23	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
24-10-17	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-07-29	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-05-30	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-26	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-04-25	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
23-11-28	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-08-28	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-05-30	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-04-26	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Manager	Title	Age	Since
James Brown CEO	Chief Executive Officer	-	2004-01-12

Director	Title	Age	Since
Janice Brown BRD	Director/Board Member	-	2004-01-12
Herbert Leary BRD	Director/Board Member	-	2010-10-24
James Brown CHM	Chairman	-	2002-10-30

Date	Insider	Type	Main position	Quantity	% Market Cap.
21-11-10	Janice Brown	Free	Director	888,036	1.3783%
21-11-10	James Brown	Free	Chief Executive Officer	888,036	1.3783%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CAPHA PHARMACEUTICALS INC.	-.--%	-99.00%	-	-	64
ELI LILLY AND COMPANY	-0.43%	+3.27%	+58.26%	+171.59%	1,102B
JOHNSON & JOHNSON	-0.34%	+4.88%	+70.98%	+66.99%	643B
ABBVIE INC.	-0.44%	+0.84%	+33.41%	+88.24%	450B
ROCHE HOLDING AG	+1.30%	-0.30%	+29.05%	+25.11%	336B
NOVARTIS AG	-0.72%	+0.86%	+29.03%	+46.98%	288B
NOVO NORDISK A/S	-1.05%	-0.09%	-28.06%	-39.03%	222B
AMGEN INC.	+0.08%	+1.84%	+23.90%	+63.74%	199B
GILEAD SCIENCES, INC.	-0.93%	+7.45%	+21.88%	+78.83%	169B
PFIZER INC.	+0.81%	+1.59%	-5.31%	-32.01%	137B
Average	-0.12%	+2.00%	+25.91%	+52.27%	393.9B
Weighted average by Cap.	-0.20%	+1.86%	+40.76%	+86.54%